Threshold dose for behavioral discrimination of cigarette nicotine content in menthol vs. non-menthol smokers

Psychopharmacology

Volumn 234, Issue 8, 2017, Pages 1255-1265

  Perkins, Kenneth A ^a   Kunkle, Nicole ^a   Karelitz, Joshua L ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Cigarette smoking; Discrimination; Menthol; Nicotine; Threshold

Indexed keywords

MENTHOL; NICOTINE;

ADULT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DECISION MAKING; FAGERSTROM TEST FOR NICOTINE DEPENDENCE; FEMALE; HUMAN; MALE; PERCEPTIVE DISCRIMINATION; REINFORCEMENT; SMOKING; ANALYSIS OF VARIANCE; DISCRIMINATION LEARNING; DOSE RESPONSE; DRUG EFFECTS; PERCEPTIVE THRESHOLD; PHYSIOLOGY; PSYCHOLOGY; TOBACCO DEPENDENCE;

ADULT; ANALYSIS OF VARIANCE; CHOICE BEHAVIOR; DISCRIMINATION LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MENTHOL; NICOTINE; REINFORCEMENT (PSYCHOLOGY); SENSORY THRESHOLDS; SMOKING; TOBACCO USE DISORDER;

EID: 85013067841     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-017-4563-3     Document Type: Article

References (64)

1. Ai J, Taylor KM, Lisko JG, Tran H, Watson CH, Holman MR (2016) Menthol content in US marketed cigarettes. Nicotine Tob Res 18:1575–1580
2. American Psychiatric Association (APA) (2013) Diagnostic and statistical manual-V. American Psychiatric Association, Washington DC
3. Audrain-McGovern J, Strasser AA, Wileyto EP (2016) The impact of flavoring on the rewarding and reinforcing value of e-cigarettes with nicotine among young adult smokers. Drug Alc Depend 166:263–267
4. Benowitz NL, Hall SM, Herning RI, Jacob P, Jones RT, Osman A-L (1983) Smokers of low-yield cigarettes do not consume less nicotine. New Engl J Med. 309:139–142
5. Benowitz NL, Henningfield JE (1994) Establishing a nicotine threshold for addiction. New Engl J Med 331:123–125
6. Benowitz NL, Henningfield JE (2013) Reducing the nicotine content to make cigarettes less addictive. Tob Control 22:i14–i17
7. Biswas L, Harrison E, Gong Y, Avusula R, Lee J, Zhang M et al (2016) Enhancing effect of menthol on nicotine self-administration in rats. Psychopharmacology 233:3417–3427
8. Blank MD, Disharoon S, Eissenberg T (2009) Comparison of methods for measurement of smoking behavior: mouthpiece-based computerized devices versus direct observation. Nicotine Tob Res 11:896–903
9. Bolin BL, Alcorn JL, Reynolds AR, Lile JA, Rush CR (2016) Human drug discrimination: a primer and methodological review. Exp Clin Psychopharmacol 24:214–228
10. Breslau N, Kilbey MM, Andreski P (1994) DSM-IIIR nicotine dependence in young adults: prevalence, correlates and associated psychiatric disorders. Addiction 89:743–754
11. Brody AL, Mandelkern MA, Costello MR, Abrams AL, Scheibal D, Farahi J et al (2009) Brain nicotinic acetylcholine receptor occupancy: effect of smoking a denicotinized cigarette. Int J Neuropsychopharmacol 12:305–312
12. Carter LP, Stitzer ML, Henningfield JE, O’Connor RJ, Cummings KM, Hatsukami DK (2009) Abuse liability assessment of tobacco products including potential reduced exposure products. Cancer Epid Biomarkers Prev 18:3241–3262
13. Chait LE, Evans SM, Grant KA, Kamien JB, Johanson CE, Schuster CR (1988) The discriminative stimulus and subjective effects of smoked marijuana in humans. Psychopharmacology 94:206–212
14. Curtin GM, Sulsky SI, Van Landingham C, Marano KM, Graves MJ, Ogden MW, Swauger JE (2014) Patterns of menthol cigarette use among current smokers, overall and within demographic strata, based on data from four U.S. government surveys. Reg Tox Pharmacol 70:189–196
15. Delnovo CD, Gundersen DA, Hrywna M et al (2011) Smoking cessation prevalence among U.S. smokers of menthol versus non-menthol cigarettes. Amer J Prev Med 41:357–365
16. Dessirier J, O’Mahony M, Carstens E (2001) Oral irritant properties of menthol: sensitizing and desensitizing effects of repeated application and cross-desensitization to nicotine. Physiol Behav 73:25–36
17. Donny EC, Denlinger RL, Tidey JW et al (2015) Randomized trial of reduced-nicotine standards for cigarettes. New Engl J Med 373:1340–1349
18. Duke AN, Johson MW, Reissig CJ, Griffiths RR (2015) Nicotine reinforcement in never-smokers. Psychopharmacology 232:4243–4252
19. Farco JA, Grundmann O (2013) Menthol—pharmacology of an important naturally medicinal “cool”. Mini-Rev Med Chem 13:124–131
20. Ferris GF, Carpenter CM (2011) Tobacco industry manipulation of nicotine dosing. In: Henningfield JE, London E, Pogun S (eds) Nicotine psychopharmacology. Springer-Verlag, New York, pp 457–485
21. Fu SS, Okuyemi KS, Partin MR et al (2008) Menthol cigarettes and smoking cessation during an aided quit attempt. Nicotine Tob Res 10:457–462
22. Glennon RA, Young R (2011) Drug discrimination: application to medicinal chemistry and drug studies. Wiley, New York
23. Grebenstein PE, Burroughs D, Roiko SA, Pentel PR, LeSage MG (2015) Predictors of the nicotine reinforcement threshold, compensation, and elasticity of demand in a rodent model of nicotine reduction policy. Drug Alc Depend 151:181–193
24. Gu X, Lohrenz T, Salas R et al (2015) Belief about nicotine selectively modulates value and reward prediction error signals in smokers. Proc Nat Acad Sci 112:2539–2544
25. Hasenfratz M, Jacober A, Battig K (1993) Smoking-related subjective and physiological changes: pre- to postpuff and pre- to postcigarette. Pharmacol Biochem Behav 46:527–534
26. Hatsukami DK, Heishman SJ, Vogel RI et al (2013) Dose-response effects of Spectrum research cigarettes. Nicotine Tob Res 15:1113–1121
27. Hatsukami DK, Perkins KA, LeSage MG, Ashley DL, Henningfield JE, Benowitz NL, Backinger C, Zeller M (2010) Nicotine reduction revisited: science and future directions. Tob Control 19:436–445
28. Hatsukami DK, Pickens RW, Svikis DS, Hughes JR (1988) Smoking topography and nicotine blood levels. Addict Behav 13:91–95
29. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom K-O (1991) The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 86:1119–1127
30. Hecht SS (2012) Research opportunities related to establishing standards for tobacco products under the Family Smoking Prevention and Tobacco Control Act. Nicotine Tob Res 14:18–28
31. Henningfield JE, Benowitz NL, Slade J, Houston TP, Davis RM, Deitchman SD (1998) Reducing the addictiveness of cigarettes. Tob Control 7:281–293
32. Johanson C-E (1991) Discriminative stimulus effects of psychomotor stimulants and benzodiazepines in humans. In: Glennon RA, Jarbe TUC, Frankenheim J (eds) Drug discrimination: applications to drug abuse research, NIDA Research Monograph, vol 116. U.S. Government Printing Office, Washington DC, pp 181–196
33. Kasza KA, Hyland AJ, Bansal-Travers M, Vogl LM, Chen J et al (2014) Switching between menthol and nonmenthol cigarettes: findings from the U.S. cohort of the interational Tobacco Control Four Country survey. Nicotine Tob Res 16:1255–1265
34. Kessler DA (1994) Statement on nicotine-containing cigarettes. Tob Control 3:148–158
35. King BA, Dube SR, Tynan MA (2012) Current tobacco use among adults in the United States: findings from the National Adult Tobacco Survey. Amer J Public Health 102:e93–e100
36. Kreslake JM, Wayne GF, Connolly GN (2008) The menthol smoker: tobacco industry research on consumer sensory perception of menthol cigarettes and its role in smoking behavior. Nicotine Tob Res 10:705–715
37. Marian C, O’Connor RJ, Djordjevic MV, Rees VW, Hatsukami DK, Shields PG (2009) Reconciling human smoking behavior and machine smoking patterns: implications for understanding smoking behavior and the impact on laboratory studies. Cancer Epid Biomarkers Prev. 18:3305–3320
38. Mishina EV, Hoffman AC (2014) Clinical pharmacology research strategy for dissolvable tobacco products. Nicotine Tob Res 16:253–262
39. Mooney M, Green C, Hatsukami D (2006) Nicotine self-administration: cigarettes versus nicotine gum diurnal topography. Hum Psychopharmacol 21:539–548
40. Morean ME, Kong G, Cavallo DA, Camenga DR, Krishnan-Sarin S (2016) Nicotine concentration of e-cigarettes used by adolescents. Drug Alc Depend 167:224–227
41. Perkins KA (2009) Discriminative stimulus effects of nicotine in humans. In: Henningfield JE, London E, Pogun S (eds) Nicotine psychopharmacology. Springer-Verlag, New York, pp 369–400
42. Perkins KA (2011). Nicotine discrimination in humans. Chapter 15 in Glennon RA, Young R (eds), Drug discrimination: application to medicinal chemistry and drug studies. New York: Wiley, pp. 463–481
43. Perkins KA, Fonte C, Sanders M, Meeker J, Wilson A (2001) Threshold doses for nicotine discrimination in smokers and nonsmokers. Psychopharmacology 155:163–170
44. Perkins KA, Grobe JE, Weiss D, Fonte C, Caggiula A (1996) Nicotine preference in smokers as a function of smoking abstinence. Pharmacol Biochem Behav 55:257–263
45. Perkins KA, Karelitz JL, Giedgowd GE, Conklin CA (2012) The reliability of puff topography and subjective responses during ad lib smoking of a single cigarette. Nicotine Tob Res 14:490–494
46. Perkins KA, Kunkle N, Michael VC, Karelitz JL, Donny EC (2016a) Assessing discrimination of nicotine in humans via cigarette smoking. Nicotine Tob Res 18:1830–1836
47. Perkins KA, Kunkle N, Karelitz JL, Michael VC, Donny EC (2016b) Threshold dose for discrimination of nicotine via cigarette smoking. Psychopharmacology 233:2309–2317
48. Perkins KA, Kunkle N, Karelitz JL (2017) Preliminary test of cigarette nicotine discrimination threshold in non-dependent versus dependent smokers. Drug Alc Depend (in press)
49. Pickworth WB, Moolchan ET, Berlin I, Murty R (2002) Sensory and physiologic effects of menthol and nonmenthol cigarettes with differing nicotine delivery. Pharmacol Biochem Behavior 71:55–61
50. Rosbrook K, Green BG (2016) Sensory effects of menthol and nicotine in an e-cigarette. Nic Tob Res 18:1588–1595
51. Slade J, Bero LA, Hanauer P, Barnes DE, Glantz SA (1995) Nicotine and addiction: the Brown and Williamson documents. JAMA 274:225–233
52. Smith SS, Fiore MC, Baker TB (2014) Smoking cessation in smokers who smoke menthol and non-menthol cigarettes. Addiction 109:2107–2117
53. Smith JW, Stolerman IP (2009) Recognising nicotine: the neurobiological basis of nicotine discrimination. In: Henningfield JE, London E, Pogun S (eds) Nicotine psychopharmacology. Springer, New York, pp 295–333
54. Sofuoglu M, LeSage MG (2012) The reinforcement threshold for nicotine as a target for tobacco control. Drug Alc Depend 125:1–7
55. SRNT subcommittee (2002) Biochemical verification of tobacco use and cessation. Nicotine Tob Res 4:149–159
56. Stolerman IP, Jarvis MJ (1995) The scientific case that nicotine is addictive. Psychopharmacology 117:2–10
57. Strasser AA, Ashare RL, Kaufman M, Tang KZ, Mesaros AC, Blair IA (2013) The effect of menthol on cigarette smoking behaviors, biomarkers and subjective responses. Cancer Epid Biomarkers Prev 22:382–389
58. Takada K (1996) Drug discrimination studies in humans: a review of methodologies. Meth Find Exp Clin Pharmacol 18(suppl 1):187–196
59. Tobacco Products Scientific Advisory Committee (TPSAC) (2011) Menthol cigarettes and public health: review of the scientific evidence and recommendations. US Food and Drug Administration, Rockville MD
60. Uhl GR, Walther DW, Behm FM, Rose JE (2011) Menthol preference among smokers: association with TRPA1 variants. Nicotine Tob Res 13:1311–1315
61. U.S. Department of Health and Human Services (USDHHS). (2010) How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease. A Report of the Surgeon General. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health.
62. U.S. Govt (2009). Family Smoking Prevention and Tobacco Control Act, Pub. L. No. 111–31; http://www.gpo.gov/fdsys/pkg/PLAW-111publ31/pdf/PLAW-111publ31.pdf
63. Villanti AC, Mowery PD, Delnevo CD, Niaura RS, Abrams DB, Giovino GA (2016) Changes in the prevalence and correlates of menthol cigarette use in the USA, 2004-2014. Tob Control 25(suppl 2):ii14–ii20
64. Yerger VB, McCandless PM (2011) Menthol sensory qualities and smoking topography: a review of tobacco industry documents. Tob Control 20(suppl 2):ii37–ii43